Domain Therapeutics grants Alkermes a non-exclusive license for its G Protein-Coupled Receptor BioSe...

Domain Therapeutics and Medicxi launch Mavalon Therapeutics, aimed at halting the progression of Par...

Domain Therapeutics, Université de Montréal, IRICoR and McGill University extend licensing and par...

PeptiMimesis: New biotech startup developing next generation therapeutic peptides in immuno-oncology...